The stake sale, involving 2.44 crore shares at Rs 580 each, is expected to raise approximately Rs 1,420 crore. Indegene ...

The healthcare tech firm's stock fell as much as 4.68 per cent during the day to ₹590 per share, the biggest intraday loss ...

Global investment firm Carlyle group on Wednesday exited Indegene by divesting its entire 10.2 per cent stake in digital ...

As many as 2.53 crore shares or 10.56% equity of Indegene Ltd worth ₹1,504 crore changed hands at ₹594 per share on Wednesday ...

With this deal, Carlyle has made a complete exit from Indegene. At the end of the March quarter, CA Dawn Investments had a 10 ...

Carlyle group exited Indegene by divesting its entire 10.2 per cent stake in digital healthcare services for Rs 1,447 crore ...

US-based private equity firm Carlyle Group recently sold its entire 10.2 per cent holding in the company, leading to a 4 per ...

PRINCETON, N.J. and BENGALURU, India, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced that it is helping AstraZeneca ...

Indegene has struck a deal with two investment companies that will see them take a $200 million minority stake in the healthtech company. The funding from The Carlyle Group and Brighton Park ...

Indegene shares saw a 4.7 percent equity stake sale in block deals aggregating as much as Rs 707 crore on Tuesday, 3 December, with private equity firm CA Dawn likely offloading a part of its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...